Statement From the American Diabetes Association Related to Studies Published in Diabetelogia Suggesting Possible Link

ALEXANDRIA, VA, Jun 26 (MARKET WIRE) --
Diabetelogia, the journal of the European Association for the Study of
Diabetes (EASD), published a series of research papers today examining a
possible link between insulin glargine (brand name, Lantus) and cancer.
Findings from these research papers are conflicting and inconclusive, and
the American Diabetes Association cautions against over-reaction until
more information is available.

Four different population based studies were reported and published in
Diabetelogia and the data within these studies and between these studies
are conflicting and confusing. Until more information is available, the
American Diabetes Association advises patients using insulin not to stop
taking it.

For patients using glargine and considering switching to another form of
insulin, the data in these studies make it unclear as to whether any one
type of insulin increases the risk of cancer more than other types of
insulin.

Patients concerned about these studies or their insulin regimen should
talk to their doctor and should not stop taking their insulin on the
basis of the findings reported here.

Insulin is a hormone normally produced by the pancreas that helps the body
use glucose for energy. All people with type 1 diabetes need to take
insulin to survive; many patients with type 2 diabetes also need to take
insulin to control their blood glucose.

Glargine insulin, which as been widely used since 2000, is an artificial
form of insulin that is typically administered once a day.

The American Diabetes Association is the nation's leading voluntary health
organization supporting diabetes research, information and advocacy. The
Association's mission is to prevent and cure diabetes and to improve the
lives of all people affected by diabetes. Founded in 1940, the Association
provides service to hundreds of communities across the country. For more
information please call the American Diabetes Association at
1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information
from both these sources is available in English and Spanish.

Contact:
Diane Tuncer
(703) 549-1500 ext. 5510
dtuncer@diabetes.org

Copyright 2009, Market Wire, All rights reserved.

-0-